Apyx Medical (APYX) Long-Term Debt Issuances (2023)

Apyx Medical (APYX) reported Long-Term Debt Issuances of $34.2 million for Q4 2023, up 268.02% quarter-over-quarter from $9.3 million in Q1 2023.

Apyx Medical (APYX) Long-Term Debt Issuances (2023) Analysis & Trends

Apyx Medical has reported Long-Term Debt Issuances for 1 years, with the latest figure at $34.2 million in Q4 2023.

For the quarter ending Q4 2023, Long-Term Debt Issuances changed N/A year-over-year to $34.2 million; the trailing twelve-month figure through Sep 2024 stood at $34.2 million (up 268.02% YoY), and the FY2023 full-year result was $43.5 million, changed N/A from the prior year.
Long-Term Debt Issuances for Q4 2023 stood at $34.2 million, up from $9.3 million in the prior quarter.
The five-year high for Long-Term Debt Issuances was $34.2 million in Q4 2023, with the low at $9.3 million in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	19.86 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	-
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	1.15 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	11.71 Mn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	-
10	Apyx Medical	205.37 Mn	174.49 Mn	7.93 Mn	-

Download Data